Clinical TrialID 2392
Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)
NCT01711684
Neoplasm Metastasis|Melanoma
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 2392
- Evidence Id
- 2392
- Core Evidence Id
- 2392
- Source Clinical Trial Id
- 2369
- Herb2 Clinical Trial Id
- HBCT002369
- Nct Id
- NCT01711684
- Title
- Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Neoplasm Metastasis|Melanoma
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Diphenylcyclopropenone (DPCP)
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 6
- Outcome Measure
- clinically evident inflammatory response elicited by DPCP and the clinically evident efficacy of DPCP to treat cutaneous metastases, Day 142
- Sponsor Collaborator
- Rockefeller University
- Funded By
- OTHER
- Location
- The Rockefeller University, New York, New York, 10065, United States
- Other Id
- JKR-0788
- Start Date
- 2012-10-16
- Primary Completion Date
- 2015-06-22
- Completion Date
- 2015-06-22
- First Posted
- 2012-10-22
- Results First Posted
- Last Update Posted
- 2017-11-29
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01711684
- Title Cn
- Title En
- Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)
- Bilingual Status
- semi_complete